首页 | 本学科首页   官方微博 | 高级检索  
     


Separation of bisdioxopiperazine- and vanadate resistance in topoisomerase II
Authors:Sorensen Tina K  Grauslund Morten  Jensen Peter B  Sehested Maxwell  Jensen Lars H
Affiliation:Department of Pathology, Diagnostic Centre RH5444, Copenhagen University Hospital, Frederik V's Vej 11, DK-2100 Copenhagen, Denmark.
Abstract:Bisdioxopiperazines are inhibitors of topoisomerase II trapping this protein as a closed clamp on DNA with concomitant inhibition of its ATPase activity. Here, we analyse the effects of N-terminal mutations identified in bisdioxopiperazine-resistant cells on ATP hydrolysis by this enzyme. We present data consistent with bisdioxopiperazine resistance arising by two different mechanisms; one involving reduced stability of the N-terminal clamp (the N-gate) and one involving reduced affinity for bisdioxopiperazines. Vanadate is a general inhibitor of type P ATPases and has recently been demonstrated to lock topoisomerase II as a salt-stable closed clamp on DNA analogous to the bisdioxopiperazines. We show that a R162K mutation in human topoisomerase II alpha renders this enzyme highly resistant towards vanadate while having little effect on bisdioxopiperazine sensitivity. The implications of these findings for the mechanism of action of bisdioxopiperazines versus vanadate with topoisomerase II are discussed.
Keywords:Bisdioxopiperazine   Vanadate   Anti-cancer agent   Topoisomerase II   ATP hydrolysis   Mutation   Drug resistance   DNA binding protein   Dexrazoxane
本文献已被 ScienceDirect PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号